ANA LAZAREVIC: Open Payments
NPI 1154964450 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 10 payments from 7 companies in 2025. Trend: 2023 $370 · 2024 $118 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $55 |
| TerSera Therapeutics LLC | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $19 |
Products named: Stivarga, TECVAYLI, RYBREVANT, Xermelo, PREVYMIS.
Industry payments across MD — which companies pay providers there.
